Funder: National Institutes of Health

Due Dates: March 13, 2026 (New, Renewal, Resubmission, Revision)

Funding Amounts: Phase I: up to $306,872 (6 months) | Phase II: up to $2,045,816 (2 years)

Summary: Supports U.S. small businesses developing technologies to address health-related social needs impacting substance use disorders (excluding alcohol use disorder).

Key Information: Clinical trials are optional; only U.S. small businesses are eligible; applications focused solely on medical care/treatment or alcohol use disorder are not responsive.